99% CAS 58066-85-6 Miltefosine Powder Anti Tumor Miltefosine Raw Powder Miltefosine

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Miltefosine
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Miltefosine
• Name: Miltefosine Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical; Anti Tumor;Anticancer
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No: 58066-85-6
• Melting Point: 232-234oc
• Mf: C21h46no4p
• MW: 407.568001
• Einecs: 622-572-6
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

99% CAS 58066-85-6 Miltefosine Powder Anti tumor Miltefosine Raw Powder Miltefosine

Product Description

Product Details

Product name	Miltefosine
Cas number	58066-85-6
Appearance	White powder
Melting point	232-234oC
MF	C21H46NO4P
MW	407.568001
EINECS	622-572-6

Miltefosine is a phospholipid drug. Chemically it is a derivative of alkylphosphocholine compounds discovered in the early 1980s. It was developed in the late 1980s as an anticancer drug. Simultaneously but independently it was found that the drug could kill Leishmania parasites, and since the mid-1990s successful clinical trials were conducted. The drug became the first (and still the only prescribed) oral drug in the treatment of leishmaniasis.
It is now known to be a broad-spectrum antimicrobial drug, active against pathogenic bacteria and fungi, as well as humantrematode Schistosoma mansoni. 

Application&Function

Miltefosine is usedfor the treatment of visceral and cutaneous leishmaniasis, and is undergoing clinical trialsfor this use in several other countries, such as Brazil and Guatemala. Several medical agents have some efficacy against visceral or cutaneous leishmaniasis, however a 2005 survey concluded that miltefosine is the only effective oral treatment for both forms of leishmaniasis. 

Miltefosine is a phospholipid drug. Chemically it is a derivative of alkylphosphocholine compounds discovered in the early 1980s. It was developed in the late 1980s as an anticancer drug. Simultaneously but independently it was found that the drug could kill Leishmania parasites, and since the mid-1990s successful clinical trials were conducted. The drug became the first (and still the only prescribed) oral drug in the treatment of leishmaniasis.It is now known to be a broad-spectrum antimicrobial drug, active against pathogenic bacteria and fungi, as well as humantrematode Schistosoma mansoni. 

Specification